WEBBER ROBERT has a total of 16 patent applications. Its first patent ever was published in 1994. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are THE BINDING SITE GROUP LTD, LUOYANG PULIKE WANTAI BIOLOGICAL TECH CO LTD and FUZHOU MAIXIN BIOTECHNOLOGY DEV CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United States | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Webber Robert | 16 |
Publication | Filing date | Title |
---|---|---|
US2013004968A1 | Sepsis blood biomarker system | |
AU4881102A | Immunoassay method employing monoclonal antibody reactive to human iNOS | |
WO03012026A1 | Apparatus and method for determining the onset and presence of sepsis conditions | |
EP1012605A1 | IMMUNOASSAY METHOD EMPLOYING MONOCLONAL ANTIBODY REACTIVE TO HUMAN iNOS | |
WO9845710A1 | IMMUNOASSAY METHOD EMPLOYING MONOCLONAL ANTIBODY REACTIVE TO HUMAN iNOS | |
US7198904B1 | Immunoassay method employing monoclonal antibody reactive to human iNOS | |
WO9606856A1 | Dopamine receptor peptides and anti-peptide antibodies | |
WO9500540A1 | Synthetic carrier and immunogen |